Eulerpool Terminal
The edge that pays for itself.
Current Cue Biopharma forecasts and price targets in August 2026
Ø Analyst Price Targets
5.10 USD
-80.46 %
Median
5.10 USD
-80.46 %
Max
6.30 USD
Min
4.04 USD
Last Price
26.10 USD
Buy
5
Hold
1
Sell
0
The average target price for Cue Biopharma is 5.10 USD. (-80.46 % below the current price)
The median price target of Cue Biopharma is 5.10 USD.
Stock analysts from many renowned investment banks are closely examining the Cue Biopharma stock. They conclude their professional Cue Biopharma stock analyses with a clear recommendation for the Cue Biopharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 5 | 1 | 0 | 5.10 USD |
| 2026-01-01 | 5 | 1 | 0 | 5.10 USD |
| 2025-12-01 | 6 | 1 | 0 | 5.10 USD |
| 2025-12-01 | 6 | 1 | 0 | 5.10 USD |
| 2025-11-01 | 6 | 1 | 0 | 4.08 USD |
| 2025-11-01 | 6 | 1 | 0 | 4.08 USD |
Cue Biopharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Cue Biopharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 12.00 M USD | -522.00 M USD | -141.70 USD |
| 2027e | 1.00 M USD | -744.00 M USD | -201.97 USD |
| 2028e | 1.00 M USD | -1.20 B USD | -326.84 USD |